TYLER FLANINGHAM: Open Payments
NPI 1538369053 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 37 payments from 12 companies in 2025. Trend: 2023 $1,499 · 2024 $1,912 · 2025 $829
Food & beverage: $829
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 8 | $186 |
| Teva Pharmaceuticals USA, Inc. | 4 | $123 |
| Axsome Therapeutics, Inc. | 5 | $117 |
| ABBVIE INC. | 5 | $107 |
| Collegium Pharmaceutical, Inc. | 5 | $102 |
| Corium, LLC | 2 | $44 |
| Vertical Pharmaceuticals, LLC | 2 | $36 |
| Neos Therapeutics, LP | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Tonix Medicines, Inc. | 1 | $24 |
Products named: HETLIOZ, AUSTEDO XR, VRAYLAR, Jornay PM, Auvelity, Azstarys, Relexxii, Adzenys XR-ODT.
Industry payments across IN — which companies pay providers there.
